Yssa DeWoody is co-founder of the Commission on Novel Technologies for Neurodevelopmental Copy Number Variants.
Yssa DeWoody
Co-founder
Commission on Novel Technologies for Neurodevelopmental Copy Number Variants
From this contributor
Lumping versus splitting with autism-linked variants: A conversation with Vanessa Vogel-Farley and Yssa DeWoody
Researchers have long studied subgroups of people who share genetic variants, but the newly formed ‘CNV Commission’ is also looking at people with shared traits across different neurodevelopmental conditions.
Lumping versus splitting with autism-linked variants: A conversation with Vanessa Vogel-Farley and Yssa DeWoody
By
Peter Hess
22 August 2022 | 5 min read
Explore more from The Transmitter
New projectome captures ‘complex beast’ of serotonin system in mice
The whole-brain map—the first of its kind in a vertebrate—identifies five distinct neuron groups.
New projectome captures ‘complex beast’ of serotonin system in mice
The whole-brain map—the first of its kind in a vertebrate—identifies five distinct neuron groups.
By
Madeline Shaw
2 October 2026 | 0 min watch
Silent, motion-resistant fMRI expands scans in behaving mice
The method, called SORDINO, captures brain images in animals while they move and interact.
Silent, motion-resistant fMRI expands scans in behaving mice
The method, called SORDINO, captures brain images in animals while they move and interact.
By
Diana Kwon
2 October 2026 | 5 min read
Autism-linked variants converge on two molecular patterns in mouse brains
Gene activity across 17 autism mouse models occurs in either of two opposing transcriptomic states, supporting the idea that diverse genetic changes may converge on a few recurring biological patterns.
Autism-linked variants converge on two molecular patterns in mouse brains
Gene activity across 17 autism mouse models occurs in either of two opposing transcriptomic states, supporting the idea that diverse genetic changes may converge on a few recurring biological patterns.
By
Giorgia Guglielmi
1 October 2026 | 4 min read